Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Paclitaxel-Induced Neuropathy
NCT06562998Completed
- Sponsor
- Beni Suef University
- Start
- Jul 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of pentoxifylline in chemotherapy-induced peripheral neuropathy (CIPN) (2 arms), sponsored by Beni Suef University. Primary endpoint: Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity subscale at 12 weeks. Started Jul 2022; status: completed.
02
Drugs
pentoxifylline
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT06562998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06562998.